v3.8.0.1

Note 10 - Revenue and Concentration of Credit Risk (Details Textual) - NIH & NIAID [Member] - USD ($)		3 Months Ended		29 Months Ended	139 Months Ended
	Sep. 18, 2014	Mar. 31, 2018	Mar. 31, 2017	Sep. 30, 2015	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2006
Unattained Funds, Contracted Commitment							$ 39,800,000
Increase in Unattained Funds, Contracted Commitment	$ 500,000			$ 5,400,000
Revenues, Total		$ 30,318	$ 77,759		$ 38,100,000
Remaining Unattained Funds Contracted Commitment		1,700,000			1,700,000
Accounts Receivable, Net, Current, Total		$ 30,318			$ 30,318	$ 31,977
Operating Expense [Member]
Unattained Funds, Contracted Commitment							38,400,000
Other Specified [Member]
Unattained Funds, Contracted Commitment							$ 1,400,000

Represents the amount of increase in unattained funds related to a contracted commitment.

+ References

No definition available.

+ Details

Name:	args_IncreaseInUnattainedFundsContractedCommitment
Namespace Prefix:	args_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The remaining amount of unattained funds contracted commitment.

+ References

No definition available.

+ Details

Name:	args_RemainingUnattainedFundsContractedCommitment
Namespace Prefix:	args_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Unattained funds related to a contracted commitment.

+ References

No definition available.

+ Details

Name:	args_UnattainedFundsContractedCommitment
Namespace Prefix:	args_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_AccountsReceivableNetCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

+ Details

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	srt_MajorCustomersAxis=args_NIHNIAIDMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=args_OtherSpecifiedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

ARGOS THERAPEUTICS INC 10-Q